Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1999;84:906-912

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, Y.
Right arrow Articles by Anderson, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y.
Right arrow Articles by Anderson, M. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arrhythmia
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Arrythmias-basic studies
(Circulation Research. 1999;84:906-912.)
© 1999 American Heart Association, Inc.


Original Contribution

Calmodulin Kinase Inhibition Prevents Development of the Arrhythmogenic Transient Inward Current

Yuejin Wu, Dan M. Roden, Mark E. Anderson

From the Departments of Medicine (Y.W., D.M.R., M.E.A.) and Pharmacology (D.M.R., M.E.A.), Vanderbilt University, Nashville, Tenn.

Correspondence to Mark Anderson, Vanderbilt University Medical Center, 315 Medical Research Building II, Nashville, TN 37232-6300. E-mail mark.anderson{at}mcmail.vanderbilt.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Abstract—Although it is widely accepted that afterdepolarizations initiate arrhythmias when action potentials are prolonged, the underlying mechanisms are unclear. In this study, we tested the hypothesis that action potential prolongation would raise intracellular calcium and thereby activate the arrhythmogenic transient inward current (Iti). Furthermore, given that Iti can be activated by sarcoplasmic reticulum Ca2+ release, we tested the hypothesis that inhibition of calmodulin (CaM) kinase would prevent Iti. Isolated rabbit ventricular myocytes were studied with whole-cell–mode voltage clamp. Stimulation with a prolonged action potential clamp, under near-physiological conditions, increased [Ca2+]i. Iti was reproducibly induced in 60 of 60 cells, but Iti was not seen with the use of a shorter action potential waveform (n=12). Iti was associated with a secondary elevation in [Ca2+]i. When [Ca2+]i buffering was enhanced by dialysis with BAPTA (20 mmol/L, n=9), no Iti was present. The Na+/Ca2+ exchanger was likely responsible for Iti, because Iti was inhibited by the Na+/Ca2+ exchanger inhibitory peptide XIP (10 µmol/L, n=6), but not by an inactive scrambled peptide (10 µmol/L, n=5) or by the Cl current antagonist niflumic acid (10 to 40 µmol/L, n=9). Activator Ca2+ from the sarcoplasmic reticulum was essential for development of Iti, because it was prevented by pretreatment with ryanodine (10 µmol/L, n=6) or thapsigargin (1 µmol/L, n=6). Two different CaM kinase inhibitory peptides (n=16) and a CaM inhibitory peptide (n=4) completely suppressed Iti. These results are consistent with the hypothesis that CaM kinase plays a role in arrhythmias related to increased [Ca2+]i.


Key Words: calmodulin kinase • sarcoplasmic reticulum • transient inward current • Ca2+-activated chloride current • Na+/Ca2+ exchanger


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Calmodulin (CaM) kinase is a ubiquitous serine/threonine kinase that has recently been shown to modulate the release of activator Ca2+ during excitation-contraction coupling in ventricular myocytes.1 CaM kinase is activated by increased [Ca2+]i2 ; once activated by Ca2+ bound to CaM, CaM kinase can undergo a series of autophosphorylation events to become Ca2+ independent.3 We have recently found that this Ca2+-independent component of CaM kinase activity increases during action potential prolongation and early afterdepolarizations (EADs) in isolated rabbit ventricle.4 CaM kinase acts at key sites for [Ca2+]i homeostasis and is known to increase L-type Ca2+ current5 6 7 and facilitate the uptake8 and release1 9 of Ca2+ by the sarcoplasmic reticulum (SR) in ventricular myocytes. Thus, CaM kinase activity could be important for the development of [Ca2+]i overload arrhythmias.

One mechanism for arrhythmias due to [Ca2+]i overload is activation of a transient inward current (Iti).10 In non–voltage-clamped cells Iti causes cell membrane depolarization resulting in delayed afterdepolarizations (DADs) and triggered arrhythmias.11 Under near-physiological conditions, Iti may be due to the electrogenic Na+/Ca2+ exchanger operating in forward mode,12 but results of other experiments performed under less physiological conditions (eg, in the absence of extracellular Na+ or after Na+/K+ ATPase inhibition) suggest that this current could also be due to a Ca2+-activated cation nonselective current (ICAN)12 13 14 15 16 or a Ca2+-activated Cl current (ICa/Cl).16 17 18 19

Many conditions such as ischemia and tachycardia20 may be associated with increased [Ca2+]i. Prolongation of action potential repolarization, a therapeutic action of a variety of antiarrhythmic agents,21 is also associated with arrhythmias in cardiomyopathy22 and congenital long-QT syndromes. Whereas the ionic mechanisms underlying action potential prolongation in these settings are becoming better understood, those underlying the accompanying afterdepolarizations and triggered arrhythmias are less well understood. In these studies, we present evidence that the elevated [Ca2+]i, which follows action potential prolongation, can activate Iti due to Na+/Ca2+ exchanger activity and that this activation is dependent on CaM kinase. These results suggest that this CaM kinase–dependent mechanism may trigger arrhythmias arising when action potentials are prolonged.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Preparation of Isolated Ventricular Myocytes
Isolation of rabbit ventricular myocytes was performed as previously described.5 New Zealand White rabbits of either sex (2 to 3 kg) were euthanized with a pentobarbital overdose (50 mg/kg, IV) after heparin infusion (150 U/kg, IV). The collagenase-containing solution was prepared in nominally Ca2+-free solution containing 60 U/mL collagenase type I from Worthington Biochemicals and 0.1 U/mL type XIV protease from Sigma. Myocytes were dispersed by gentle agitation and then maintained in standard saline solution containing 1.8 mmol/L CaCl2. Myocytes were studied within 8 hours after dispersion. Only rod-shaped quiescent myocytes with clear striations from the left ventricle were studied.

Solutions
The solutions for preparation of isolated ventricular myocytes were described previously.5 The bath solution contained (in mmol/L) NaCl 140.0, HEPES 5.0, glucose 10.0, KCl 5.4, CaCl2 2.5, and MgCl2 1.0. The pH was adjusted to 7.4 with 10 N NaOH. The intracellular solution contained (in mmol/L) potassium aspartate 120.0, HEPES 5.0, KCl 25.0, disodium ATP 4.0, MgCl2 1.0, disodium phosphocreatine 2.0, and sodium GTP 2.0. The pH was adjusted to 7.2 with 1 N KOH. In some experiments, the Cl current antagonist niflumic acid23 was added to the bath solution for a final concentration of 10 to 40 µmol/L. The SR Ca2+ release channel blocker ryanodine (10 µmol/L) or the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase antagonist thapsigargin (1 µmol/L, Calbiochem) were included in other experiments. Thapsigargin was added as a DMSO stock solution with a final DMSO concentration of 0.0001 vol %. Unless otherwise noted, all chemicals were from Sigma.

Electrophysiology
Current Clamp
Cells were stimulated at 0.1 Hz in current clamp mode with 1.0- to 2.0-nA pulses of depolarizing current (1.25 times threshold) for 3 to 4 ms at room temperature (20°C to 23°C). Action potentials were low pass filtered at 2 kHz and sampled at 2.5 kHz with a 12-bit analog to digital converter (Digidata 1200 B) from Axon Instruments. Representative short (APD50=194 ms; APD90=217 ms) and long (APD50=422; APD90=561 ms) action potential waveforms were digitized and stored for application as voltage commands for most experiments using pClamp 6.03 (Figure 1Down).



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Effect of stimulation with a long and short action potential waveform. A, Stimulation with a long action potential waveform resulted in Iti after completion of repolarization, as indicated (arrow). Outward deflection at the terminal portion of the action potential clamp was likely the inward rectifier K+ current as it was abolished by 0.5 mmol/L Ba2+ (not shown). B, Stimulation with a short action potential waveform failed to elicit Iti. An inward current was present coincidentally with terminal repolarization using the short, but not the long, action potential waveform and was likely the result of repolarization-associated forward-mode Na+/Ca2+ exchanger activity, as described by other investigators.12 39 Both waveforms were applied at 0.5 Hz. C, The steady-state [Ca2+]i transient was greater during stimulation with the long than with the short AP waveform.

Voltage Clamp
Isolated myocytes were studied with whole-cell–mode voltage-clamp configuration at 32°C on a heated stage (Warner Instrument Corp) using an amplifier (Axopatch 200B, Axon Instruments), as previously described.4 5 Micropipette electrode resistance was 1.5 to 3.5 M{Omega} when micropipettes were filled with the intracellular solution. Membrane currents were low pass filtered at 2 kHz and sampled at 6.7 kHz. The digitized signals were stored for later analysis with pClamp 6.03 (Axon Instruments) and Sigma Plot (Jandel Scientific). Cell membrane capacitance (167±2.2 pF) was measured using the integral of the current transient after a 10-mV hyperpolarizing step from a holding potential of –80 mV or a 10-mV depolarizing step from a holding potential of 0 mV.

Iti Measurement
After a dialysis-and-stabilization period of >=5 minutes, cells were repetitively (>=50 times) depolarized at 0.5 Hz with either a long or a short action potential command waveform (Figure 1Up). The presence or absence of oscillatory currents after completion of repolarization (Iti) was noted during the first 50 depolarizations, and peak Iti was measured as the difference between the current at the onset of the oscillation and the current at maximum excursion of the oscillation. Oscillatory currents were also induced at different test potentials following conventional conditioning steps (0.5 Hz) from –80 to +10 or +30 mV (Figure 2DDown).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Iti is likely due to the Na+/Ca2+ exchanger. A through C, Data tracings from separate myocytes stimulated with the long action potential waveform (Figure 1AUp). A, Tracing from a myocyte dialyzed with XIP, which prevented Iti. B, Inactive control peptide sXIP did not prevent Iti. C, Niflumic acid did not suppress Iti. D, Schematic depiction of conditioning and test command voltages, applied at 0.5 Hz, used to generate the raw data tracings (E) and current-voltage relationships (F). E, Oscillatory currents (single arrows) in response to a range of test cell membrane potential (Vm) steps with Vm indicated next to each tracing. The large inward current present at the –80-mV test Vm was the inward rectifier, because it was abolished by addition of Ba2+ (0.5 mmol/L) (not shown). A small oscillatory biphasic current was present in later conditioning steps (double arrows) and was absent in XIP-treated cells. Erev for the oscillatory currents was not changed by reversing the order of test Vm commands (not shown). F, Current-voltage relationship of the oscillatory currents. Oscillatory inward currents were prevented by dialysis with XIP. XIP significantly reduced peak currents (P<=0.005) at all test potentials except for –80 mV (P=0.06) and +60 mV (P=0.059) relative to control. Niflumic acid did not affect the inward currents but significantly reduced the outward current at +40 (P=0.003) and +60 mV (P=0.026) compared with control.

[Ca2+]i Measurements
Fluo 3
[Ca2+]i was monitored to compare the effect of long and short action potential waveforms on [Ca2+]i by including the pentapotassium salt of the fluorescent Ca2+ indicator fluo 3 (Molecular Probes) in the pipette solution (100 µmol/L) as previously described, with minor modifications.5 Voltage signals were low pass filtered at 50 Hz before analysis. Steady-state fluo 3 [Ca2+]i transients were integrated using pClamp 6.03.

Indo 1
The pentapotassium salt of the ratiometric Ca2+ indicator indo 1 (100 to 300 µmol/L) was dialyzed into cells to verify a secondary increase in [Ca2+]i during Iti. Excitation light was band pass filtered (360±20 nm) and reflected with a dichroic mirror (375 nm, Omega Optical) to the myocyte on the inverted microscope stage (Nikon). Emission light (ie, >375 nm) was reflected through an adjustable window to exclude extraneous fluorescence, split with a second dichroic mirror (455 nm), and represented as the ratio of 405±20/500±20 nm. Photobleaching was limited to 10% of peak output by an electronically controlled shutter device (Uniblitz) for both indo 1 and fluo 3 experiments.

Inhibitory Peptides
In separate experiments, cells were dialyzed for >=5 minutes with inhibitory peptides against CaM kinase, protein kinase A (PKA), and protein kinase C (PKC) before the experimental protocol was initiated. CaM kinase was inhibited with the following peptides (20 µmol/L): 273-302, 291-317, and AC3-I (KKALHRQEAVDCL).24 The inhibitory peptide 273-302 is modeled after the autoinhibitory region of CaM kinase and competitively binds to the catalytic site, whereas peptide 291-317 is modeled after the CaM binding region and so competitively inhibits CaM kinase and other CaM-dependent processes.2 5 The amino acid sequence HRQEAVDC in AC3-I corresponds to the surrounding autophosphorylation site on CaM kinase, except that T (Thr286/287) is modified to A (Ala) to prevent phosphorylation. Thus, AC3-I is a modified CaM kinase substrate that competitively inhibits (in vitro IC50, {approx}3 µmol/L) interaction of activated CaM kinase with substrate.24 Other serine threonine kinases are not significantly inhibited by AC3-I at the concentration used in these experiments.24 The peptide AC3-C (KKALHAQERVDCL) has no inhibitory activity24 and was included in the pipette solution (20 µmol/L) in control experiments. CaM kinase inhibitory peptides were prepared using a solid-phase peptide synthesizer (Applied Biosystems) and purified by reverse-phase HPLC. The sequences were confirmed by automated sequencing. These peptides were generous gifts of Dr Howard Schulman (Stanford University, Stanford, Calif).

The competitive PKA inhibitory peptide (IC50=0.2 µmol/L) corresponds to positions 6 to 22 of PKA and was included in the pipette solution at 10 µmol/L. The competitive PKC inhibitory peptide (IC50=0.3 µmol/L) corresponds to the autoinhibitory domain positions 19 to 36 of PKC and was included in the pipette solution at 20 µmol/L. Both PKA and PKC inhibitory peptides were obtained commercially (Gibco-BRL). The Na+/Ca2+ exchanger inhibitory peptide (XIP) is modeled after a putative CaM binding site on the Na+/Ca2+ exchanger and acts to potently inhibit Na+/Ca2+ exchanger current in ventricular myocytes when included in the dialysate (10 or 20 µmol/L).25 Scrambled XIP (sXIP) does not affect the Na+/Ca2+ exchanger and was included in the pipette solution (10 µmol/L) for the control experiments.26 Both XIP and sXIP were generous gifts from Dr Kenneth Philipson (UCLA, Los Angeles, Calif).


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowReferences
 
The Transient Inward Current Follows Stimulation With a Long Action Potential Waveform
Stimulation using a prolonged action potential waveform reproducibly induced Iti in 60 of 60 cells (Figure 1AUp). In some cases, Iti followed every stimulation using the long action potential waveform, but in other experiments, Iti occurred in an alternating pattern. Stimulation with a shorter action potential waveform under identical conditions failed to elicit Iti (n=12) (Figure 1BUp).

The Transient Inward Current Is Likely Due to the Na+/Ca2+ Exchanger
Iti was not observed in any (n=6) of the XIP-treated cells (Figure 2AUp), but was present in all (n=5) cells treated with sXIP (Figure 2BUp). In another group of cells, niflumic acid (n=9) failed to prevent Iti (Figure 2CUp). These experiments therefore suggest that Iti may be due to forward-mode Na+/Ca2+ exchange current. When conventional square wave conditioning steps were used to activate the oscillatory current (Figure 2DUp and 2EUp), the reversal potential (Erev) was between +20 and +40 mV (Figure 2FUp), which is far different from the calculated Erev for Cl (–45 mV) or monovalent cations (–2 mV) under these experimental conditions. Treatment with niflumic acid only significantly inhibited outward current at +40 and +60 mV compared with control and did not affect inward current or Erev (Figure 2FUp). XIP prevented inward current oscillations and shifted Erev in a positive direction (Figure 2FUp). The measured Erev for the oscillatory currents, the lack of effect of niflumic acid, and the suppression of Iti by XIP are all consistent with the hypothesis that the predominant mechanism underlying Iti was the Na+/Ca2+ exchanger.

The [Ca2+]i Transient Is Greater With the Long Than the Short Action Potential Waveform
Integrated fluo 3 fluorescence from paired experiments (Figure 1CUp) showed that the steady-state [Ca2+]i transient with the long action potential (557±89 Vxms) was significantly greater than that measured during the short action potential (328±28 Vxms) waveform (P=0.04, n=5). These results are consistent with previous reports that show that prolonged action potential duration is associated with increased [Ca2+]i27 and suggest that increased [Ca2+]i is important for Iti.

The Transient Inward Current Is Associated With Secondary [Ca2+]i Oscillations
Myocytes dialyzed with indo 1 and exhibiting Iti (n=3) showed a secondary [Ca2+]i oscillation after completion of the long action potential step. Myocytes without Iti (n=10) did not have secondary [Ca2+]i oscillations. Similar observations were made in fluo 3–loaded cells. These findings provide further evidence that the Iti measured in this study is dependent on an increase in [Ca2+]i.

The Transient Inward Current Is Dependent on Activator Ca2+ From the SR
Addition of BAPTA completely inhibited Iti after stimulation with the long action potential waveform in 9 of 9 cells studied. Because the release of SR Ca2+ stores has been linked to Iti, Iti inducibility was tested after exposure to ryanodine (n=6) or thapsigargin (n=6). Iti was not inducible after exposure to either of these agents. These findings support the hypothesis that Iti is linked to increased [Ca2+]i and specifically indicates that participation of SR activator Ca2+ is necessary for Iti after stimulation with a prolonged action potential waveform.

The Transient Inward Current Is Dependent on CaM Kinase
To test whether CaM kinase is necessary for Iti, cells were dialyzed with specific CaM kinase inhibitory peptides. Dialysis with AC3-I (n=11), 273-302 (n=5), or 291-317 (n=4) completely abolished Iti after stimulation with the prolonged action waveform (Figure 3Down). Dialysis of the inactive control peptide AC3-C (n=6) had no apparent effect and failed to inhibit Iti. Like XIP, the CaM kinase inhibitory peptide AC3-I also inhibited oscillatory inward currents in response to test potentials from –80 to +20 mV (Figure 4Down) but, unlike XIP (Figure 2FUp), AC3-I did not change the Erev.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 3. Effect of kinase inhibitory peptides on development of Iti. Shown are representative original data tracings of cells stimulated with the long action potential waveform (Figure 1AUp) after dialysis with inhibitory peptides. Inactive control peptide AC3-C did not prevent Iti (A). The CaM kinase inhibitory peptides AC3-I (B) and 273-302 (C) and the CaM inhibitory peptide 291-317 (D) all prevented Iti. Inhibitory peptides against PKA (E) and PKC (F) failed to prevent Iti.



View larger version (20K):
[in this window]
[in a new window]
 
Figure 4. Current-voltage relationship of the oscillatory currents in response to the test voltage commands shown in Figure 2DUp. The control cells are the same as those shown in Figure 2EUp. Dialysis with AC3-I inhibited both inward and outward oscillatory currents without changing the apparent Erev. The inactive control peptide AC3-C was without effect.

Both PKA and PKC may also participate in [Ca2+]i homeostasis.9 28 29 To test for a possible role of these kinases in Iti development, cells were dialyzed with suprainhibiting concentrations of protein kinase A inhibitor (PKI 6-22) (n=6) and PKC 19-36 (n=5), and neither of these inhibitory peptides prevented Iti (Figure 3Up). These results suggest that Iti is dependent on CaM and CaM kinase, but not on PKC or PKA, under these experimental conditions.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowReferences
 
Action Potential Prolongation, Arrhythmogenesis, and [Ca2+]i
Action potential prolongation has both antiarrhythmic and proarrhythmic consequences. Since the Cardiac Arrhythmia Suppression Trial30 demonstrated that potent Na+ channel blocking agents resulted in excess mortality, considerable effort has been expended to develop safer antiarrhythmic agents. Most of these agents prolong action potential repolarization. With the exception of amiodarone, which has multiple actions, including CaM antagonism,31 all of these agents cause significant proarrhythmia. Proarrhythmia from action potential prolongation is thought to result from triggering due to EADs and subsequent functional reentry.21

Action potential prolongation results in increased [Ca2+]i (Figure 1CUp),27 and increased CaM kinase activity3 4 ; both of these actions have been linked to EADs.4 28 Iti underlies DADs and is another cause of arrhythmia due to elevated [Ca2+]i and oscillatory release of SR activator Ca2+.11 32 Because CaM kinase has recently been shown to enhance SR Ca2+ release during excitation-contraction coupling,1 we hypothesized that CaM kinase would facilitate Iti. The present findings show that a prolonged action potential waveform increases [Ca2+]i under steady-state conditions and results in Iti. Iti measured in response to the prolonged action potential waveform has dependence on SR activator Ca2+ similar to that of previously measured11 32 currents during [Ca2+]i overload under near-physiological conditions.

It is increasingly recognized that prolongation of action potential repolarization is an important cause of increased [Ca2+]i27 and that it is associated with lethal arrhythmias in a variety of settings.21 22 Many studies have implicated EADs as an arrhythmogenic trigger when action potential is prolonged. However, most such studies use block of the rapid component of the delayed rectifier (IKr) to prolong action potentials, especially at slow rates.21 Action potential prolongation that persists at fast heart rates is characteristic of blockade of the slow component of the delayed rectifier (IKs), and it is now known that the most common cause of long-QT syndrome is mutations in the KVLQT1 gene, which encodes IKs components.21 Importantly, preliminary reports have implicated DADs as the arrhythmogenic mechanism when IKs is blocked and isoproterenol is added to the experimental preparation.33 The onset of torsade de pointes occurs with adrenergic stress in >95% of patients with mutations in KVLQT1, according to preliminary reports.34 Our findings suggest a possible mechanism for arrhythmias due to action potential prolongation and point out possible proarrhythmic consequences of using IKs blocking agents for antiarrhythmic therapy.

The Identity of the Transient Inward Current
Previous studies have generally concluded that the predominant inward current after a depolarizing step is due to (forward-mode) Na+/Ca2+ exchanger current in the presence of physiological solutions.12 35 However, other candidate currents include ICa/Cl and ICAN.12 13 14 15 16 17 18 19 Our findings suggest that Iti measured in these experiments is due to Na+/Ca2+ exchanger current for the following reasons. (1) Iti is inhibited by XIP, but not by the inactive control peptide sXIP (Figure 2Up). (2) Erev for the oscillatory current is approximately +30 mV, which is far different from that predicted for ICa/Cl (–45 mV) or ICAN (–2 mV) but consistent with previously reported values under similar experimental conditions, in which both the Na+/Ca2+ exchanger current and ICa/Cl were present.17 36 (3) Iti is not inhibited by niflumic acid (Figure 2CUp). Niflumic acid did reduce outward currents at positive potentials (Figure 2FUp), which is consistent with the described outward rectification of ICa/Cl.19 These results suggest that Iti is due to the Na+/Ca2+ exchanger and that ICa/Cl is present but significant only at relatively depolarized cell membrane potentials under these conditions. One recent report in ferret ventricular myocytes found that the time course for activation of the Na+/Ca2+ exchanger current was slower than for ICa/Cl, making Erev measurement problematic.37 Limitations to our conclusion that Iti is due to the Na+/Ca2+ exchanger in these experiments are that (1) no antagonists are available to exclude participation of ICAN, and (2) XIP is a CaM antagonist over the range of concentrations useful for inhibition of the Na+/Ca2+ exchanger.38 Thus, inhibition of Iti by XIP could occur partially via a CaM kinase–dependent mechanism analogous to the inhibition with the CaM inhibitory peptide 291-317 (Figure 3DUp). It is interesting to note that XIP shifted the apparent Erev for the oscillatory current (Figure 2FUp), whereas the specific CaM kinase inhibitory peptide AC3-I did not (Figure 4Up), which suggests that XIP effects are not solely due to CaM kinase inhibition and therefore likely reflect inhibition of the Na+/Ca2+ exchanger.

CaM Kinase Inhibition
The specific inhibitory peptides used in these experiments offer a significant advantage over other organic inhibitors, because the latter are also ICa-L antagonists.1 4 5 Two different peptides modeled after separate regions of the CaM kinase molecule were effective at suppressing Iti (Figure 3BUp, 3CUp, and 4Up). A less specific inhibitory peptide with antagonist actions against CaM (and presumably a diverse array of CaM-dependent processes, including CaM kinase) was also effective at preventing Iti (Figure 3DUp). Thus, inhibitory peptides acting at 3 different sites along the CaM kinase activation pathway were all effective in preventing Iti. In contrast, inhibitory peptides against PKA or PKC did not prevent Iti. Although these studies do show that CaM kinase activity appears necessary for Iti, the results do not precisely define or quantify the site(s) of action of CaM kinase inhibition for Iti suppression. One possibility is that enhanced [Ca2+]i activates CaM kinase, which, in turn, augments SR Ca2+ uptake and release to secondarily activate Iti caused by forward-mode Na+/Ca2+ exchange. These results strongly support the hypothesis that CaM kinase facilitates Iti due to the Na+/Ca2+ exchanger during increased [Ca2+]i. CaM kinase may thus be a useful antiarrhythmic drug target to prevent arrhythmias related to [Ca2+]i overload.


*    Acknowledgments
 
This work was supported by NIH Grants HL03727 (to M.E.A.) and HL46681 and HL49989 (to D.M.R.) and a Cardiac Arrhythmia Research and Education Foundation, Inc, award (to M.E.A.). D.M.R. holds the William Stokes chair in Experimental Therapeutics, a gift of the Dai-ichi Corp.

Received October 1, 1998; accepted February 1, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*References
 

  1. Li L, Satoh H, Ginsburg KS, Bers DM. The effect of Ca(2+)-calmodulin-dependent protein kinase II on cardiac excitation-contraction coupling in ferret ventricular myocytes. J Physiol. 1997;501:17–31.[Medline] [Order article via Infotrieve]
  2. Braun AP, Schulman H. The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. Annu Rev Physiol. 1995;57:417–445.[Medline] [Order article via Infotrieve]
  3. De Koninck P, Schulman H. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science. 1998;279:227–230.[Abstract/Free Full Text]
  4. Anderson ME, Braun AP, Wu Y, Lu T, Schulman H, Sung RJ. KN-93, an inhibitor of multifunctional Ca2+/calmodulin dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther. 1998;287:996–1006.[Abstract/Free Full Text]
  5. Anderson ME, Braun AP, Schulman H, Premack BA. Multifunctional Ca2+/calmodulin-dependent protein kinase mediates Ca2+-induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes. Circ Res. 1994;75:854–861.[Abstract/Free Full Text]
  6. Yuan W, Bers DM. Ca-dependent facilitation of cardiac Ca current is due to Ca- calmodulin-dependent protein kinase. Am J Physiol. 1994;267:H982–H993.[Abstract/Free Full Text]
  7. Xiao RP, Cheng H, Lederer WJ, Suzuki T, Lakatta EG. Dual regulation of Ca2+/calmodulin-dependent kinase II activity by membrane voltage and by calcium influx. Proc Natl Acad Sci U S A. 1994;91:9659–9663.[Abstract/Free Full Text]
  8. Reddy LG, Jones LR, Pace RC, Stokes DL. Purified, reconstituted cardiac Ca2+-ATPase is regulated by phospholamban but not by direct phosphorylation with Ca2+/calmodulin-dependent protein kinase. J Biol Chem. 1996;271:14964–14970.[Abstract/Free Full Text]
  9. Hain J, Onoue H, Mayrleitner M, Fleischer S, Schindler H. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem. 1995;270:2074–2081.[Abstract/Free Full Text]
  10. Clusin WT. Caffeine induces a transient inward current in cultured cardiac cells. Nature. 1983;301:248–250.[Medline] [Order article via Infotrieve]
  11. Matsuda H, Noma A, Kurachi Y, Irisawa H. Transient depolarization and spontaneous voltage fluctuations in isolated single cells from guinea pig ventricles: calcium-mediated membrane potential fluctuations. Circ Res. 1982;51:142–151.[Abstract/Free Full Text]
  12. Giles W, Shimoni Y. Comparison of sodium-calcium exchanger and transient inward currents in single cells from rabbit ventricle. J Physiol (Lond). 1989;417:465–481.[Abstract/Free Full Text]
  13. Ehara T, Noma A, Ono K. Calcium-activated non-selective cation channel in ventricular cells isolated from adult guinea-pig hearts. J Physiol (Lond). 1988;403:117–133.[Abstract/Free Full Text]
  14. Colquhoun D, Neher E, Reuter H, Stevens CF. Inward current channels activated by intracellular Ca in cultured cardiac cells. Nature. 1981;294:752–754.[Medline] [Order article via Infotrieve]
  15. Cannell MB, Lederer WJ. The arrhythmogenic current ITI in the absence of electrogenic sodium-calcium exchange in sheep cardiac Purkinje fibres. J Physiol (Lond). 1986;374:201–219.[Abstract/Free Full Text]
  16. Han X, Ferrier GR. Ionic mechanisms of transient inward current in the absence of Na(+)-Ca2+ exchange in rabbit cardiac Purkinje fibres. J Physiol (Lond). 1992;456:19–38.[Abstract/Free Full Text]
  17. Laflamme MA, Becker PL. Ca2+-induced current oscillations in rabbit ventricular myocytes. Circ Res. 1996;78:707–716.[Abstract/Free Full Text]
  18. Collier ML, Levesque PC, Kenyon JL, Hume JR. Unitary Cl channels activated by cytoplasmic Ca2+ in canine ventricular myocytes. Circ Res. 1996;78:936–944.[Abstract/Free Full Text]
  19. Zygmunt AC, Gibbons WR. Properties of the calcium-activated chloride current in heart. J Gen Physiol. 1992;99:391–414.[Abstract/Free Full Text]
  20. Lee HC, Smith N, Mohabir R, Clusin WT. Cytosolic calcium transients from the beating mammalian heart. Proc Natl Acad Sci U S A. 1987;84:7793–7797.[Abstract/Free Full Text]
  21. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome: current knowledge, gaps, and future directions: the SADS Foundation Task Force on LQTS. Circulation. 1996;94:1996–2012.[Abstract/Free Full Text]
  22. Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res. 1996;78:262–273.[Abstract/Free Full Text]
  23. Terracciano CM, MacLeod KT. Measurements of Ca2+ entry and sarcoplasmic reticulum Ca2+ content during the cardiac cycle in guinea pig and rat ventricular myocytes. Biophys J. 1997;72:1319–1326.[Abstract/Free Full Text]
  24. Braun AP, Schulman H. A non-selective cation current activated via the multifunctional Ca(2+)-calmodulin-dependent protein kinase in human epithelial cells. J Physiol (Lond). 1995;488:37–55.[Medline] [Order article via Infotrieve]
  25. Chin TK, Spitzer KW, Philipson KD, Bridge JH. The effect of exchanger inhibitory peptide (XIP) on sodium-calcium exchange current in guinea pig ventricular cells. Circ Res. 1993;72:497–503.[Abstract/Free Full Text]
  26. Kohomoto O, Levi AJ, Bridge JH. Relation between reverse sodium-calcium exchange and sarcoplasmic reticulum calcium release in guinea pig ventricular cells. Circ Res. 1994;74:550–554.[Abstract/Free Full Text]
  27. Bouchard RA, Clark RB, Giles WR. Effects of action potential duration on excitation-contraction coupling in rat ventricular myocytes: action potential voltage- clamp measurements. Circ Res. 1995;76:790–801.[Abstract/Free Full Text]
  28. Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. Am J Physiol. 1990;258:H1796–H1805.[Abstract/Free Full Text]
  29. Johnson JA, Gray MO, Chen CH, Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem. 1996;271:24962–24966.[Abstract/Free Full Text]
  30. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991;324:781–788.[Abstract]
  31. Silver PJ, Connell MJ, Dillon KM, Cumiskey WR, Volberg, WA, Ezrin AM. Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents. Cardiovasc Drugs Ther. 1989;3:675–682.[Medline] [Order article via Infotrieve]
  32. Thandroyen FT, Morris AC, Hagler HK, Ziman B, Pai L, Willerson JT, Buja LM. Intracellular calcium transients and arrhythmia in isolated heart cells. Circ Res. 1991;69:810–819.[Abstract/Free Full Text]
  33. Burashnikov A, Antzelevitch C. IKs block promotes ß-adrenergic agonist-induced delayed afterdepolarization activity in canine ventricular myocardium. Circulation. 1998;96(suppl I):I-293. Abstract.
  34. Schwartz PJ, Moss AJ, Priori SG, Wang Q, Lehmann MH, Timothy K, Denjoy I, Haverkamp W, Giucheney P, Paganini V, Scheinman MM, Karnes PS. Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome. Circulation. 1997;96 (suppl I):I-212. Abstract.
  35. Kimura J, Miyamae S, Noma A. Identification of sodium-calcium exchange current in single ventricular cells of guinea-pig. J Physiol (Lond). 1987;384:199–222.[Abstract/Free Full Text]
  36. Kimura J, Noma A, Irisawa H. Na-Ca exchange current in mammalian heart cells. Nature. 1986;319:596–597.[Medline] [Order article via Infotrieve]
  37. Trafford AW, Diaz ME, Eisner DA. Ca-activated chloride current and Na-Ca exchange have different timecourses during sarcoplasmic reticulum Ca release in ferret ventricular myocytes. Pflugers Arch. 1998;435:743–745.[Medline] [Order article via Infotrieve]
  38. Li Z, Nicoll DA, Collins A, Hilgemann DW, Filoteo AG, Penniston JT, Weiss JN, Tomich JM, Philipson KD. Identification of a peptide inhibitor of the cardiac sarcolemmal Na(+)-Ca2+ exchanger. J Biol Chem. 1991;266:1014–1020.[Abstract/Free Full Text]
  39. Grantham CJ, Cannell MB. Ca2+ influx during the cardiac action potential in guinea pig ventricular myocytes. Circ Res. 1996;79:194–200.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
PhysiologyHome page
L. F. Couchonnal and M. E. Anderson
The Role of Calmodulin Kinase II in Myocardial Physiology and Disease
Physiology, June 1, 2008; 23(3): 151 - 159.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
H. E. D. J. ter Keurs and P. A. Boyden
Calcium and Arrhythmogenesis
Physiol Rev, April 1, 2007; 87(2): 457 - 506.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. E. Anderson
Multiple downstream proarrhythmic targets for calmodulin kinase II: Moving beyond an ion channel-centric focus
Cardiovasc Res, March 1, 2007; 73(4): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Li, C. Marionneau, R. Zhang, V. Shah, J. W. Hell, J. M. Nerbonne, and M. E. Anderson
Calmodulin Kinase II Inhibition Shortens Action Potential Duration by Upregulation of K+ Currents
Circ. Res., November 10, 2006; 99(10): 1092 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
G. P. Zaloga, K. A. Harvey, W. Stillwell, and R. Siddiqui
Trans Fatty Acids and Coronary Heart Disease
Nutr Clin Pract, October 1, 2006; 21(5): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. P. Zaloga, N. Ruzmetov, K. A. Harvey, C. Terry, N. Patel, W. Stillwell, and R. Siddiqui
(n-3) Long-Chain Polyunsaturated Fatty Acids Prolong Survival following Myocardial Infarction in Rats
J. Nutr., July 1, 2006; 136(7): 1874 - 1878.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. E. Anderson
The Fire From Within: The Biggest Ca2+ Channel Erupts and Dribbles
Circ. Res., December 9, 2005; 97(12): 1213 - 1215.
[Full Text] [PDF]


Home page
Circ. Res.Home page
X. Ai, J. W. Curran, T. R. Shannon, D. M. Bers, and S. M. Pogwizd
Ca2+/Calmodulin-Dependent Protein Kinase Modulates Cardiac Ryanodine Receptor Phosphorylation and Sarcoplasmic Reticulum Ca2+ Leak in Heart Failure
Circ. Res., December 9, 2005; 97(12): 1314 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Zhang and J. H. Brown
Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure
Cardiovasc Res, August 15, 2004; 63(3): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
Y. Wu, J. T. Kimbrough, R. J. Colbran, and M. E. Anderson
Calmodulin kinase is functionally targeted to the action potential plateau for regulation of L-type Ca2+ current in rabbit cardiomyocytes
J. Physiol., January 1, 2004; 554(1): 145 - 155.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. M. Roden
A Surprising New Arrhythmia Mechanism in Heart Failure
Circ. Res., October 3, 2003; 93(7): 589 - 591.
[Full Text] [PDF]


Home page
CirculationHome page
M. R. Rosen
Blunderbuss to Mickey Mouse: The Evolution of Antiarrhythmic Targets
Circulation, September 3, 2002; 106(10): 1180 - 1182.
[Full Text] [PDF]


Home page
CirculationHome page
Y. Wu, J. Temple, R. Zhang, I. Dzhura, W. Zhang, R. Trimble, D. M. Roden, R. Passier, E. N. Olson, R. J. Colbran, et al.
Calmodulin Kinase II and Arrhythmias in a Mouse Model of Cardiac Hypertrophy
Circulation, September 3, 2002; 106(10): 1288 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Deschenes, N. Neyroud, D. DiSilvestre, E. Marban, D. T. Yue, and G. F. Tomaselli
Isoform-Specific Modulation of Voltage-Gated Na+ Channels by Calmodulin
Circ. Res., March 8, 2002; 90 (4): e49 - e57.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. D. Gbadebo, R. W. Trimble, M. S.C. Khoo, J. Temple, D. M. Roden, and M. E. Anderson
Calmodulin Inhibitor W-7 Unmasks a Novel Electrocardiographic Parameter That Predicts Initiation of Torsade de Pointes
Circulation, February 12, 2002; 105(6): 770 - 774.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Members of the Sicilian Gambit
New Approaches to Antiarrhythmic Therapy, Part II: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias
Circulation, December 11, 2001; 104(24): 2990 - 2994.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias
Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias
Cardiovasc Res, December 1, 2001; 52(3): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D. M RODEN and M. E ANDERSON
The pause that refreshes, or does it? Mechanisms in torsades de pointes
Heart, September 1, 2000; 84(3): 235 - 237.
[Full Text] [PDF]